Clopidogrel to Treat Patients With Non–ST-Segment Elevation Acute Coronary Syndromes After Hospital Discharge
Authors:
- Pierluigi TricociPTPierluigi Tricoci
- Matthew T. RoeMRMatthew T. Roe
- Jyotsna MulgundJMJyotsna Mulgund
- L. Kristin NewbyLNL. Kristin Newby
- Sidney C. SmithSSSidney C. Smith
- Charles V. PollackCPCharles V. Pollack
- Dan J. FintelDFDan J. Fintel
- Christopher P. CannonCCChristopher P. Cannon
- Deepak L. BhattDBDeepak L. Bhatt
- W. Brian GiblerWGW. Brian Gibler
- E. Magnus OhmanEOE. Magnus Ohman
- Eric D. PetersonEPEric D. Peterson
Open Access
- 10 April 2006
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 166 (7) , 806-811
Abstract
Non–ST-segment elevation acute coronary syndromes (NSTE ACS) result in approximately 1.4 million admissions to US hospitals each year.1 In the past decade, antiplatelet and antithrombotic drugs for the treatment of NSTE ACS that have shown benefits in randomized clinical trials have been incorporated into clinical practice guidelines.2-5Keywords
This publication has 1 reference indexed in Scilit:
- Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment ElevationNew England Journal of Medicine, 2001